CHIR 98014 is a highly potent and selective GSK-3 inhibitor (IC50 values are 0.58 and 0.65 nM for the β and α isoforms, respectively). Exhibits >500-fold selectivity for GSK-3β over a range of other kinases. Improves insulin sensitivity of muscle strips from diabetic rats
in vitro
and decreases insulin and glucose levels in the oral glucose tolerance test
in vivo
Caractéristiques techniques
| Marque | Tocris |
| Réf. B-LABO | BL-RE-151630 |
| Réf. fabricant | 18708596 |
| Quantité | 5 mg |
|---|
| Formule moléculaire | C<sub>20</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub> |
|---|
| Poids de la formule | 486.31 |
|---|
| Type de produit | Inhibitor |
|---|
| Pureté | 98% |
Une question, une configuration particulière ?
Contactez-nous pour un devis.